132 related articles for article (PubMed ID: 15496649)
1. Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
Bonate PL; Craig A; Gaynon P; Gandhi V; Jeha S; Kadota R; Lam GN; Plunkett W; Razzouk B; Rytting M; Steinherz P; Weitman S
J Clin Pharmacol; 2004 Nov; 44(11):1309-22. PubMed ID: 15496649
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias.
Gandhi V; Kantarjian H; Faderl S; Bonate P; Du M; Ayres M; Rios MB; Keating MJ; Plunkett W
Clin Cancer Res; 2003 Dec; 9(17):6335-42. PubMed ID: 14695132
[TBL] [Abstract][Full Text] [Related]
4. Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
Cooper T; Kantarjian H; Plunkett W; Gandhi V
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1417-23. PubMed ID: 15571270
[TBL] [Abstract][Full Text] [Related]
5. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
Jeha S; Gandhi V; Chan KW; McDonald L; Ramirez I; Madden R; Rytting M; Brandt M; Keating M; Plunkett W; Kantarjian H
Blood; 2004 Feb; 103(3):784-9. PubMed ID: 14551141
[TBL] [Abstract][Full Text] [Related]
6. Plasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates.
Berg SL; Bonate PL; Nuchtern JG; Dauser R; McGuffey L; Bernacky B; Blaney SM
Clin Cancer Res; 2005 Aug; 11(16):5981-3. PubMed ID: 16115942
[TBL] [Abstract][Full Text] [Related]
7. Clofarabine and nelarabine: two new purine nucleoside analogs.
Gandhi V; Plunkett W
Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
Koh K; Ogawa C; Okamoto Y; Kudo K; Inagaki J; Morimoto T; Mizukami H; Ecstein-Fraisse E; Kikuta A
Int J Hematol; 2016 Aug; 104(2):245-55. PubMed ID: 27086352
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.
Kearns CM; Blakley RL; Santana VM; Crom WR
Cancer Res; 1994 Mar; 54(5):1235-9. PubMed ID: 7906999
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Jeha S; Gaynon PS; Razzouk BI; Franklin J; Kadota R; Shen V; Luchtman-Jones L; Rytting M; Bomgaars LR; Rheingold S; Ritchey K; Albano E; Arceci RJ; Goldman S; Griffin T; Altman A; Gordon B; Steinherz L; Weitman S; Steinherz P
J Clin Oncol; 2006 Apr; 24(12):1917-23. PubMed ID: 16622268
[TBL] [Abstract][Full Text] [Related]
11. Clofarabine: in pediatric patients with acute lymphoblastic leukemia.
Curran MP; Perry CM
Paediatr Drugs; 2005; 7(4):259-64; discussion 265-6. PubMed ID: 16117562
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
[TBL] [Abstract][Full Text] [Related]
13. Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Kline JP; Larson RA
Expert Opin Pharmacother; 2005 Dec; 6(15):2711-8. PubMed ID: 16316309
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Kantarjian H; Gandhi V; Cortes J; Verstovsek S; Du M; Garcia-Manero G; Giles F; Faderl S; O'Brien S; Jeha S; Davis J; Shaked Z; Craig A; Keating M; Plunkett W; Freireich EJ
Blood; 2003 Oct; 102(7):2379-86. PubMed ID: 12791647
[TBL] [Abstract][Full Text] [Related]
15. Clofarabine in pediatric acute leukemia: current findings and issues.
Hijiya N; Barry E; Arceci RJ
Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
[TBL] [Abstract][Full Text] [Related]
16. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.
Steinherz PG; Shukla N; Kobos R; Steinherz L
Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253
[TBL] [Abstract][Full Text] [Related]
17. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Larson ML; Venugopal P
Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
[TBL] [Abstract][Full Text] [Related]
18. Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Larson RA
Semin Oncol; 2007 Dec; 34(6 Suppl 5):S13-20. PubMed ID: 18086342
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
[TBL] [Abstract][Full Text] [Related]
20. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
Dressel A; Kwari M; McGreal AM
Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]